InTest Corporation
DE ˙ DB ˙ US4611471008
13,40 € ↓ -0,70 (-4,96%)
2026-06-04
DEL PRIS
SecurityDE:IN9 / InTest Corporation
InstitutionBarclays Plc
Latest Disclosed Ownership11,846 shares
Latest Disclosed Value $ 88,490
Barclays Plc reports 0.16% decrease in ownership of IN9 / InTest Corporation

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 11,846 shares of InTest Corporation (DE:IN9) valued at $75,222 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 11,865 shares of InTest Corporation. This represents a change in shares of -0.16% during the quarter. The current value of the position is $158,736 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F INTEST COM 461147100 11,846 -19 -0.16 88 -4.35 0.0000
2026-03-31 2025-09-30 13F/A-3 INTEST COM 461147100 11,865 19 0.16 93 6.98 0.0000
2026-03-19 2025-09-30 13F/A-2 INTEST COM 461147100 13,473 1,627 98 0.0000
2025-11-12 2025-09-30 13F INTEST COM 461147100 11,865 19 93 0.0000
2026-02-27 2025-06-30 13F/A-2 INTEST COM 461147100 11,846 0 0.00 86 4.88 0.0000
2025-08-14 2025-06-30 13F/A-1 INTEST COM 461147100 11,846 0 0 0.0000
2025-08-13 2025-06-30 13F INTEST COM 461147100 11,846 0 0 0.0000
2026-03-17 2025-03-31 13F/A-1 INTEST COM 461147100 11,846 -1,627 -12.08 83 -28.70 0.0000
2025-05-15 2025-03-31 13F INTEST COM 461147100 11,846 -1,627 0 0.0000
2026-03-19 2024-12-31 13F/A-1 INTEST COM 461147100 13,473 0 0.00 116 17.35 0.0000
2025-02-13 2024-12-31 13F INTEST COM 461147100 13,473 0 0 0.0000
2026-03-31 2024-09-30 13F/A-2 INTEST COM 461147100 13,473 -185 -1.35 98 -26.87 0.0000
2024-11-19 2024-09-30 13F/A-1 INTEST COM 461147100 13,473 -185 0 0.0000
2024-11-15 2024-09-30 13F INTEST COM 461147100 13,473 -185 0 0.0000
2026-03-23 2024-06-30 13F/A-1 INTEST COM 461147100 13,658 680 5.24 135 -21.64 0.0000
2024-08-14 2024-06-30 13F INTEST COM 461147100 13,658 680 0 0.0000
2026-03-24 2024-03-31 13F/A-1 INTEST COM 461147100 12,978 -7,825 -37.61 172 -39.36 0.0001
2024-05-15 2024-03-31 13F INTEST COM 461147100 12,978 -7,825 0 0.0001
2026-03-25 2023-12-31 13F/A-1 INTEST COM 461147100 20,803 13,282 176.60 283 147.37 0.0001
2024-02-15 2023-12-31 13F INTEST COM 461147100 20,803 13,282 0 0.0001
2026-03-26 2023-09-30 13F/A-1 INTEST COM 461147100 7,521 4,649 161.87 114 52.00 0.0001
2023-11-07 2023-09-30 13F INTEST COM 461147100 7,521 4,649 0 0.0001
2026-03-30 2023-06-30 13F/A-2 INTEST COM 461147100 2,872 -4,575 -61.43 75 -51.30 0.0000
2023-09-20 2023-06-30 13F/A-1 INTEST COM 461147100 2,872 -4,575 0 0.0000
2023-08-03 2023-06-30 13F INTEST COM 461147100 2,872 -4,575 0 0.0000
2026-03-30 2023-03-31 13F/A-1 INTEST COM 461147100 7,447 7,447 154 0.0001
2023-05-04 2023-03-31 13F INTEST COM 461147100 7,447 7,447 0 0.0001
2022-02-23 2021-12-31 13F/A-1 INTEST COM 461147100 0 -1,926 -100.00 0 -100.00
2022-02-14 2021-12-31 13F INTEST COM 461147100 0 -1,926 0
2021-11-09 2021-09-30 13F INTEST COM 461147100 1,926 1,344 230.93 22 120.00 0.0000
2021-08-13 2021-06-30 13F INTEST COM 461147100 582 582 10 0.0000
2020-11-12 2020-09-30 13F INTEST COM 461147100 0 -33 -100.00 0 -100.00 0.0000
2020-08-12 2020-06-30 13F INTEST COM 461147100 33 33 0 0.0000
2020-05-13 2020-03-31 13F INTEST COM 461147100 0 -1 -100.00 0 0.0000
2020-02-10 2019-12-31 13F INTEST COM 461147100 1 -64 -98.46 0 0.0000
2019-11-15 2019-09-30 13F/A-1 INTEST COM 461147100 65 65 0 0.0000
2019-11-14 2019-09-30 13F INTEST COM 461147100 65 65 0 0.0000
2018-05-15 2018-03-31 13F INTEST COM 461147100 0 -1,267 -100.00 0 -100.00
2018-02-14 2017-12-31 13F INTEST COM 461147100 1,267 1,267 11 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.